Authors
Latest:
Advocating for Patients with Diabetic NephropathyAlthough no cure exists, pharmacologic and nonpharmacologic measures can help patients prevent onset or progression of diabetic nephropathy to preserve kidney function.
Latest:
Initiating Drug Therapy in Multiple Sclerosis Patients: Effect on Healthcare CostsMultiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.
Latest:
Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and DiabetesA value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.
Latest:
Job Market TrendsEmployers and pharmacy school students sometimes have differing perceptions of what it takes to successfully obtain a job in community pharmacy.
Latest:
Cost Outcomes of Diabetes Education in a Specialized Community PharmacyDiabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.
Latest:
Hepatitis C: Oral Direct-Acting Antivirals Are Standard of CareChronic hepatitis C virus (HCV) infection, estimated to affect up to 4 million Americans, is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplant.
Latest:
2017 Specialty Trend in Senior CareThe shifting landscape in specialty dispensing among pharmacies that service patients in senior care settings and long-term care facilities.
Latest:
Editor's Note: Are Intravenous Fluids Becoming a Commodity?With the widespread use of the intravenous route in many settings, safeguards are needed.
Latest:
Study Supports Recent Change in GINA GuidelinesA recent study demonstrated that budesonide-formoterol is superior to albuterol for as-needed exacerbation prevention in mild asthma.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
Job Market TrendsEmployers and pharmacy school students sometimes have differing perceptions of what it takes to successfully obtain a job in community pharmacy.
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Avoiding Antimicrobial Misuse: Delaying the Postantibiotic EraAppropriate antimicrobial use is critical because almost 70% of bacterial infections resulting in death are resistant to at least one antimicrobial.
Latest:
CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory LymphomasPatients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Latest:
Incentive Formularies: Spending and Utilization for 3 Common Drug ClassesIncentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Latest:
Sinking the TitanicQuestions of cost and value are ones that each stakeholder group in healthcare will have to answer.
Latest:
What Lies Ahead For Pharmacists in 2021This year, pharmacists’ role will continue to evolve because of, or despite, the COVID-19 pandemic.
Latest:
Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other EvidenceNumerous studies have supported the use of motivational interviewing in health care to reduce cholesterol level, blood pressure, blood alcohol level, and weight.
Latest:
Spot Heart Failure a Mile AwayTelemedicine and remote monitoring advancements can help prevent hospitalizations for the condition.
Latest:
Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia PharmacotherapyThis study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Future of Sanofi's Inhalable Insulin in DoubtDisappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.
Latest:
Aimovig Can Cut the Number of Migraine DaysThe human monoclonal antibody helps treat the painful and often debilitating condition.
Latest:
AML Genomic Landscape Plays Key Role in TreatmentNumerous therapeutic options are available for acute myeloid leukemia, but more research is needed to determine how best to use them.
